Two stocks in Specialty Chemicals
L'Air Liquide vs Novonesis A/S: profit, growth, debt and price compared
Novonesis A/S is stronger on 4 of 7 figures: profit margin, sales growth, debt and price for its expected profit. L'Air Liquide is stronger on 3: dividend, analysts' view and price trend.
Save both stocks to your watchlist and revisit their latest fundamentals.
| L'Air LiquideAI.PA | Novonesis A/SNSIS-B.CO | |
|---|---|---|
| Net margin | 13.1% | Stronger: 15.6% |
| Revenue growth, past year | +0.80% | Stronger: +7.10% |
| Debt to equity | 63.3% | Stronger: 27.9% |
| Forward P/E | 26.4× | Stronger: 26.0× |
| Dividend yield | Stronger: 1.74% | 1.46% |
| Analysts | Stronger: Strong buy · 20 | Buy · 15 |
| From its 200-day average | Stronger: +12.8% | +6.9% |
Share price over the past year
- L'Air Liquide+25.8%
- Novonesis A/S+12.4%
21 Nov 202518 Nov 2026
L'Air Liquide or Novonesis A/S: which is stronger?
- NSIS-B.CO
Which is more profitable?
Novonesis A/S keeps more of each sale as profit: 15.6% against 13.1%.
- NSIS-B.CO
Which is growing its sales faster?
Novonesis A/S is growing its sales faster: +7.10% over the past year, against +0.80%.
- NSIS-B.CO
Which has borrowed less?
Novonesis A/S has borrowed less: its debt is 27.9% of what its shareholders own, against 63.3% for L'Air Liquide.
- NSIS-B.CO
Which costs less for the profit it is expected to make?
Novonesis A/S costs less for the profit it is expected to make: 26.0× its forward earnings, against 26.4×.
- AI.PA
Which pays more in dividends?
L'Air Liquide pays more back in dividends for what a share costs: 1.74% a year, against 1.46%.
- AI.PA
Which do analysts rate higher?
Analysts are warmer on L'Air Liquide: Strong buy, against Buy for Novonesis A/S.
- AI.PA
Which is in the stronger price trend?
L'Air Liquide's price is in the stronger trend: 12.8% above its 200-day average, against 6.9% above.
What each company does
AI.PAL'Air Liquide
L'Air Liquide S.A. provides gases, technologies, and services for the industrial and health sectors in Europe, the Americas, the Asia Pacific, the Middle East, and Africa.
Reports results on 19 February 2027
NSIS-B.CONovonesis A/S
Novonesis A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America.
Reports results on 24 February 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.